Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in NAFLD
NCT01084486Phase 2Completed
- Sponsor
- Edith Wolfson Medical Center
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in non-alcoholic fatty liver disease (NAFLD), sponsored by Edith Wolfson Medical Center. Status: completed.
02
Drugs
metformin
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT01084486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01084486.